Tarsus Pharmaceuticals Inc.

Last updated September 27, 2026

Favorite this organization

Organization details

Legal name: Tarsus Pharmaceuticals Inc.
Ownership: Public
Status: Active
Sector (GICS): Health Care
SIC code: 2836 — Biological Products, (No Diagnostic Substances)
Jurisdiction of incorporation: Delaware
Headquarters city: Irvine
Headquarters state / province: California
Headquarters country: United States
Fiscal year end: December
Ticker symbol: TARS
Primary stock exchange: Nasdaq

Identifiers

SEC CIK: 0001819790
EIN: 81-4717861

Board of directors

Follow this board

Andrew D. Goldberg · Director
Since 2023
Bhaskar Chaudhuri · Director
Since 2023
Bobak R. Azamian · Director · President/CEO and Board Chair
Since 2023
David E. I. Pyott · Director
Since 2026
Elizabeth Yeu Lin · Director
Since 2023
Katherine Goodrich · Director
Since 2024
Rosemary A. Crane · Director
Since 2023
Scott W. Morrison · Director Overboarded
Since 2023
Wendy L. Yarno · Director
Since 2023
William J. Link Ph.D. · Director
Since 2023

Chief executives

Bobak R. Azamian · President/CEO and Board Chair

Dates unknown

Director election results

Annual meeting of June 25, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

8 of this board's directors also sit on 16 other boards. 15 are in the same sector.

Shared director Other board Same sector

IDEAYA Biosciences Inc. Same sector
via Scott W. Morrison and Wendy L. Yarno
Achieve Life Sciences Inc. Same sector
via Andrew D. Goldberg
Alnylam Pharmaceuticals Inc. Same sector
via David E. I. Pyott
Arcutis Biotherapeutics Inc. Same sector
via Bhaskar Chaudhuri
BioMarin Pharmaceutical Inc. Same sector
via David E. I. Pyott
Certara Inc.
via Rosemary A. Crane
Corvus Pharmaceuticals Inc. Same sector
via Scott W. Morrison
Inovio Pharmaceuticals Inc. Same sector
via Wendy L. Yarno
Iovance Biotherapeutics Inc. Same sector
via Wendy L. Yarno
LENSAR Inc. Same sector
via William J. Link Ph.D.
Pliant Therapeutics Inc. Same sector
via David E. I. Pyott
RxSight Inc. Same sector
via William J. Link Ph.D.
STAAR Surgical Company Same sector
via Elizabeth Yeu Lin
Teva Pharmaceutical Industries Limited Same sector
via Rosemary A. Crane
Vera Therapeutics Inc. Same sector
via Scott W. Morrison
Zai Lab Limited Same sector
via Scott W. Morrison

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months: $0; 0 purchases by 0 insiders
Sold, last 12 months: $19,956,603; 59 sales by 9 insiders

Date	Insider	Transaction	Shares	Price	Value
Sep 15, 2026	William J. Link Ph.D. Director	Option exercise	+201	—	—
Sep 15, 2026	David E. I. Pyott Director	Option exercise	+201	—	—
Sep 15, 2026	Wendy L. Yarno Director	Option exercise	+302	—	—
Sep 15, 2026	William J. Link Ph.D. Director	Open-market sale	−11,675	$78.33	$914,503
Sep 15, 2026	William J. Link Ph.D. Director	Open-market sale	−759	$79.00	$59,961
Sep 15, 2026	William J. Link Ph.D. Director	Open-market sale	−66	$80.01	$5,281
Sep 4, 2026	Bobak R. Azamian Director, Officer (President/CEO and Board Chair)	Open-market sale	−7,100	$90.27	$640,917
Sep 4, 2026	Elizabeth Yeu Lin Officer (Chief Medical Officer)	Open-market sale	−5,387	$85.00	$457,895
Sep 4, 2026	Neervannan Seshadri Officer (Chief Operating Officer)	Open-market sale	−4,564	$85.00	$387,940
Sep 4, 2026	Bobak R. Azamian Director, Officer (President/CEO and Board Chair)	Open-market sale	−2,900	$91.27	$264,683
Sep 4, 2026	Elizabeth Yeu Lin Officer (Chief Medical Officer)	Open-market sale	−5,386	$90.00	$484,740
Sep 4, 2026	Elizabeth Yeu Lin Officer (Chief Medical Officer)	Open-market sale	−1,590	$85.00	$135,150
Sep 4, 2026	Elizabeth Yeu Lin Officer (Chief Medical Officer)	Open-market sale	−1,590	$90.00	$143,100
Sep 2, 2026	Bobak R. Azamian Director, Officer (President/CEO and Board Chair)	Open-market sale	−10,000	$80.06	$800,600
Sep 2, 2026	Elizabeth Yeu Lin Officer (Chief Medical Officer)	Open-market sale	−5,387	$80.00	$430,960

Peers

Compare boards

Organizations in the same sector, closest in location and size first.

3M Company NYSE: MMM · ST Paul, United States Organization ABVC BioPharma Inc. Nasdaq: ABVC · Fremont, United States Organization ACADIA Pharmaceuticals Inc. Nasdaq: ACAD · SAN Diego, United States Organization ADMA Biologics Inc Nasdaq: ADMA · Ramsey, United States Organization

Questions about Tarsus Pharmaceuticals Inc.

Who is the CEO of Tarsus Pharmaceuticals Inc.?

Bobak R. Azamian is Tarsus Pharmaceuticals Inc.'s President/CEO and Board Chair.

How many directors are on Tarsus Pharmaceuticals Inc.'s board?

Tarsus Pharmaceuticals Inc.'s board has 10 directors: Andrew D. Goldberg, Bhaskar Chaudhuri, Bobak R. Azamian, David E. I. Pyott, Elizabeth Yeu Lin, Katherine Goodrich, Rosemary A. Crane, Scott W. Morrison, Wendy L. Yarno and William J. Link Ph.D.

Are Tarsus Pharmaceuticals Inc. insiders buying or selling shares?

Over the last 12 months, Tarsus Pharmaceuticals Inc. insiders made no open-market purchases and sold $20.0 million of shares in 59 sales on the open market, as reported to the SEC on Forms 4 and 5.

How is Tarsus Pharmaceuticals Inc. connected to…? → Spot something wrong? Report a correction

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="tarsus-pharmaceuticals-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

No reviews yet. Be the first to write one.